Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

This study has been completed.
Information provided by (Responsible Party):
Laboratoire français de Fractionnement et de Biotechnologies Identifier:
First received: August 29, 2012
Last updated: November 8, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)